Publications in collaboration with researchers from Hospital General Universitario de Valencia (8)

2023

  1. Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis

    Journal of cardiovascular pharmacology, Vol. 81, Núm. 1, pp. 70-75

2022

  1. Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID-REAL registry

    European Journal of Clinical Investigation, Vol. 52, Núm. 12

  2. Sex Differences in Low-Density Lipoprotein Cholesterol Reduction with PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry

    Journal of Cardiovascular Pharmacology, Vol. 79, Núm. 4, pp. 523-529

2021

  1. Sex-Specific Ventricular Arrhythmias and Mortality in Cardiac Resynchronization Therapy Recipients

    JACC: Clinical Electrophysiology, Vol. 7, Núm. 6, pp. 705-715

2010

  1. Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma

    Genes Chromosomes and Cancer, Vol. 49, Núm. 5, pp. 439-451

2008

  1. Comparison of Benefits and Mortality in Cardiac Resynchronization Therapy in Patients With Atrial Fibrillation Versus Patients in Sinus Rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study)

    American Journal of Cardiology, Vol. 102, Núm. 4, pp. 444-449

2005

  1. Resincronización en la insuficiencia cardíaca. ¿Con o sin desfibrilador?

    Revista Espanola de Cardiologia Suplementos, Vol. 5, Núm. B

1997

  1. Role of Doppler echocardiography in the management of chronic coronary artery disease

    Revista Espanola de Cardiologia, Vol. 50, Núm. 1, pp. 15-25